Oxford Biomedica plc (LSE:OXB) entered into a sale and purchase agreement to acquire additional 3.2% stake in ABL EUROPE S.A.S. from TSGH on December 4, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
228.5 GBX | +3.86% | +12.56% | +3.86% |
Apr. 18 | Stifel Upgrades Oxford BioMedica to Buy from Hold, Lifts PT | MT |
Apr. 18 | HSBC likes Haleon, cuts Flutter to 'hold' | AN |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.86% | 285M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- OXB Stock
- News Oxford Biomedica plc
- Oxford Biomedica plc entered into a sale and purchase agreement to acquire additional 3.2% stake in ABL EUROPE S.A.S. from TSGH.